Concepedia

Author

Vincent A. Miller

Foundation Medicine (United States)ORCID

Also Known As

Gaurav Singal, Helen Boyle, Miller, Vincent A., Siraj Ali, Sun, James X., V A Miller, VINCENT MILLER, Vincent A Miller, Vincent A. Miller, Vincent Miller

1.2K

Publications

89.1K

Citations

126

H-Index

118

Concepts

All Affiliations

Foundation Medicine (United States)Memorial Sloan Kettering Cancer CenterAlbany Medical Center HospitalCornell UniversityThe University of Texas MD Anderson Cancer Center
VA

About

Vincent A. Miller is an author at Foundation Medicine (United States) specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

64

136

21.7K

2

Health Sciences

21

31

2.6K

3

Engineering

13

14

8.3K

4

Natural Sciences

1

1

60

5

Public Health

1

1

17

Vincent A. Miller

×

358

Publications

81K

Citations

124

H-Index

YearCitations

EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib

William Pao, Vincent A. Miller, Maureen F. Zakowski,

Proceedings of the National Academy of Sciences

2004

4.3K

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

Zachary R. Chalmers, Caitlin Connelly, David Fabrizio,

Genome Medicine

2017

3.6K

Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

William Pao, Vincent A. Miller, Katerina Politi,

PLoS Medicine

2005

3.5K

Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with <i>EGFR</i> -Mutant Lung Cancers

Helena A. Yu, Maria E. Arcila, Natasha Rekhtman,

Clinical Cancer Research

2013

2.4K

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova,

Molecular Cancer Therapeutics

2017

2.3K

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

Garrett M. Frampton, Alex Fichtenholtz, Geoff Otto,

Nature Biotechnology

2013

2.1K

Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

Marcin Imieliński, Alice H. Berger, Peter S. Hammerman,

Cell

2012

1.8K

Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

Giuseppe Giaccone, Roy S. Herbst, Christian Manegold,

Journal of Clinical Oncology

2004

1.7K

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

Roy S. Herbst, Giuseppe Giaccone, Joan H. Schiller,

Journal of Clinical Oncology

2004

1.7K

<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib

James Bean, Cameron Brennan, Jin‐Yuan Shih,

Proceedings of the National Academy of Sciences

2007

1.6K

Page 1